Literature DB >> 18457901

Pdcd4 protein and mRNA level alterations do not correlate in human lung tumors.

Svetlana V Kalinichenko1, Eugene P Kopantzev, Elena V Korobko, Irina V Palgova, Larisa E Zavalishina, Maria V Bateva, Andrey N Petrov, Georgii A Frank, Eugene D Sverdlov, Igor V Korobko.   

Abstract

Pdcd4 (programmed cell death 4) gene is tumor suppressor which expression is frequently down-regulated in tumors, which is considered as a diagnostic and prognostic marker as well as promising target for anti-cancer therapy. Pdcd4 protein is a target for post-translational regulation by phosphorylation marking Pdcd4 for degradation. We questioned if Pdcd4 mRNA decline in human lung tumors is accompanied by proportional depletion of Pdcd4 protein. We found that Pdcd4 protein-to-mRNA ratio varies greatly in human lung cancer cell lines. In squamous cell carcinoma samples where Pdcd4 mRNA suppression was found to be a typical event, Pdcd4 protein level frequently remained unchanged or even up-regulated. Our studies demonstrate that at least in squamous cell carcinoma, alterations in Pdcd4 mRNA and protein levels are not directly linked, and this fact should be taken into consideration when developing Pdcd4-based anti-cancer therapeutic approaches.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18457901     DOI: 10.1016/j.lungcan.2008.03.022

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  13 in total

1.  Protein kinase GSK3β regulates tumor suppressor Pdcd4 expression in lung cancer cells.

Authors:  P N Vikhreva; E V Korobko; I V Korobko
Journal:  Dokl Biochem Biophys       Date:  2012-03-15       Impact factor: 0.788

2.  Loss of programmed cell death 4 induces apoptosis by promoting the translation of procaspase-3 mRNA.

Authors:  K Eto; S Goto; W Nakashima; Y Ura; S-I Abe
Journal:  Cell Death Differ       Date:  2011-09-30       Impact factor: 15.828

3.  Expression of tumor suppressor programmed cell death 4 in endometrioid endometrial carcinomas and clinicopathological significance.

Authors:  Yanping Liu; Han Sun; Hongju Mao; Meng Gao; Xiao Tan; Yue Li; Yan Li; Guy Mutangala Muloye; Lining Zhang; Xiaoyan Wang; Zengtao Wei
Journal:  Oncol Lett       Date:  2018-04-17       Impact factor: 2.967

4.  uPAR antibody (huATN-658) and Zometa reduce breast cancer growth and skeletal lesions.

Authors:  Niaz Mahmood; Ani Arakelian; Haseeb Ahmed Khan; Imrana Tanvir; Andrew P Mazar; Shafaat A Rabbani
Journal:  Bone Res       Date:  2020-04-17       Impact factor: 13.567

Review 5.  The Role and Interactions of Programmed Cell Death 4 and its Regulation by microRNA in Transformed Cells of the Gastrointestinal Tract.

Authors:  William Frank Ferris
Journal:  Front Oncol       Date:  2022-06-29       Impact factor: 5.738

6.  Programmed cell death 4 mechanism of action: The model to be updated?

Authors:  Polina N Vikhreva; Svetlana V Kalinichenko; Igor V Korobko
Journal:  Cell Cycle       Date:  2017-08-30       Impact factor: 4.534

7.  Histone demethylase KDM2A promotes tumor cell growth and migration in gastric cancer.

Authors:  Yufeng Huang; Yiqian Liu; Lijiang Yu; Jing Chen; Juan Hou; Lihua Cui; De Ma; Wangkun Lu
Journal:  Tumour Biol       Date:  2014-09-23

8.  Expression of the stress response oncoprotein LEDGF/p75 in human cancer: a study of 21 tumor types.

Authors:  Anamika Basu; Heather Rojas; Hiya Banerjee; Irena B Cabrera; Kayla Y Perez; Marino De León; Carlos A Casiano
Journal:  PLoS One       Date:  2012-01-19       Impact factor: 3.240

9.  Loss of Programmed cell death 4 (Pdcd4) associates with the progression of ovarian cancer.

Authors:  N A Wei; Stephanie S Liu; Thomas H Y Leung; Kar F Tam; Xiao Y Liao; Annie N Y Cheung; Karen K L Chan; Hextan Y S Ngan
Journal:  Mol Cancer       Date:  2009-09-03       Impact factor: 27.401

10.  LEDGF/p75 Overexpression Attenuates Oxidative Stress-Induced Necrosis and Upregulates the Oxidoreductase ERP57/PDIA3/GRP58 in Prostate Cancer.

Authors:  Anamika Basu; Christina K Cajigas-Du Ross; Leslimar Rios-Colon; Melanie Mediavilla-Varela; Tracy R Daniels-Wells; Lai Sum Leoh; Heather Rojas; Hiya Banerjee; Shannalee R Martinez; Stephanny Acevedo-Martinez; Carlos A Casiano
Journal:  PLoS One       Date:  2016-01-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.